KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Edwards Lifesciences (EW) Shares Issued (2016 - 2025)

Edwards Lifesciences has reported Shares Issued over the past 17 years, most recently at $32.3 million for Q4 2025.

  • Quarterly results put Shares Issued at $32.3 million for Q4 2025, up 12.94% from a year ago — trailing twelve months through Dec 2025 was $174.1 million (down 3.01% YoY), and the annual figure for FY2025 was $174.1 million, down 3.01%.
  • Shares Issued for Q4 2025 was $32.3 million at Edwards Lifesciences, down from $34.7 million in the prior quarter.
  • Over the last five years, Shares Issued for EW hit a ceiling of $62.1 million in Q1 2024 and a floor of $27.5 million in Q4 2022.
  • Median Shares Issued over the past 5 years was $36.1 million (2022), compared with a mean of $41.4 million.
  • Biggest five-year swings in Shares Issued: skyrocketed 48.21% in 2024 and later decreased 19.65% in 2025.
  • Edwards Lifesciences' Shares Issued stood at $33.9 million in 2021, then decreased by 18.88% to $27.5 million in 2022, then grew by 20.73% to $33.2 million in 2023, then dropped by 13.86% to $28.6 million in 2024, then rose by 12.94% to $32.3 million in 2025.
  • The last three reported values for Shares Issued were $32.3 million (Q4 2025), $34.7 million (Q3 2025), and $57.2 million (Q2 2025) per Business Quant data.